NanoValent Pharmaceuticals Announces Issuance of United States Patent…

PRWeb
This post was originally published on this site

NanoValent Pharmaceuticals, Inc., today announced the acceptance and formal publication of United States Patent No. 10,369,104 from the U.S. Patent and Trademark Office relating to its application of…

(PRWeb August 20, 2019)

Read the full story at https://www.prweb.com/releases/nanovalent_pharmaceuticals_announces_issuance_of_united_states_patent_for_application_of_targeted_polymerized_nanoparticles_in_cancer_treatment/prweb16513020.htm